Denmark-based medical device company Sense A/S just announced a €4.5 million ($5.9 million) round of funding from venture fund SEED Capital and Vaekstfonden to help it refine its cuffless blood pressure measurement device. The company expects to secure FDA 510(K) clearance for the device and have it launch commercially next year. (Last year SEED invested $2.3 million in another Danish startup,...
Skip Fleshman, a Managing Partner at Asset Management Ventures, shared a few tips for those mobile health startups looking to become more that just "one-trick pony" developers of successful apps. In order to capitalize on their real potential and become a long-term, viable business, Fleshman has a few lessons learned to share based on his firm's investments in a number of health startups,...
Raising venture capital for a startup mHealth company is a difficult but not-impossible task, according to a panel of investors and industry watchers who discussed the subject at this week's mHealth Summit.
The "Raising Capital" panel focused on tips from investors intended for young companies that are seeking funding. The panel, which included Howard Burde (Howard Burde Health Law), Beth Cohen (...
PharmaSecure announced this week a $3.9 million investment round led by ex-Google CEO Eric Schmidt's Innovation Endeavors. Other investors included Gray Ghost Ventures, Healthtech Capital and the TEEC Angel Fund. Healthtech Capital lead a $200,000 investment round for PharmaSecure in September.
In a post for MobiHealthNews in May, Healthtech founder Don Ross singled out Eric Schmidt when writing...
NovaSom, an Obstructive Sleep Apnea (OSA) management company, announced recently that it has closed $35 million in equity financing. The investment was led by Safeguard Scientifics, as well as previous investors including TPG Biotechnology II Fund and Quaker BioVentures.
In a press release, the company stated their intent to use the funding for growth, expansion in payer and provider markets, and...
Earlier this month PricewaterhouseCoopers published its Innovation Scorecard for the medical device industries in nine countries. The bottomline conclusion was that the US will continue to dominate but emerging markets like China, India and Brazil. In other words: Nothing new here, folks.
The scorecard evaluated each country based on five criteria, which PwC says has helped the US stay on top for...
